The present invention relates to a group of peptidic compounds which haveaffinity for toxins and especially for bacterial toxins, such aslipopolysaccharide or lipoteichoic acid. These compounds can inhibit orneutralize the toxins. In addition, the present invention relates to the useof these compounds as therapeutic or diagnostic agents.